Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Goldenwell Biotech (GWLL) Interest Expenses (2020 - 2025)

Goldenwell Biotech filings provide 4 years of Interest Expenses readings, the most recent being $2100.0 for Q3 2025.

  • On a quarterly basis, Interest Expenses changed 0.0% to $2100.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $10500.0, a 66.67% increase, with the full-year FY2024 number at $8400.0, up 447.23% from a year prior.
  • Interest Expenses hit $2100.0 in Q3 2025 for Goldenwell Biotech, roughly flat from $2100.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4200.0 in Q4 2024 to a low of -$1272.0 in Q4 2021.
  • Median Interest Expenses over the past 3 years was $2100.0 (2024), compared with a mean of $1754.0.
  • The widest YoY moves for Interest Expenses: up 5060.0% in 2021, down 3161.54% in 2021.
  • Goldenwell Biotech's Interest Expenses stood at -$1272.0 in 2021, then soared by 430.19% to $4200.0 in 2024, then crashed by 50.0% to $2100.0 in 2025.
  • The last three reported values for Interest Expenses were $2100.0 (Q3 2025), $2100.0 (Q2 2025), and $2100.0 (Q1 2025) per Business Quant data.